PRGO:NYE-Perrigo Company PLC (USD)

COMMON STOCK | Drug Manufacturers - Specialty & Generic |

Last Closing

USD 25.72

Change

+0.10 (+0.39)%

Market Cap

N/A

Volume

1.35M

Analyst Target

USD 57.88
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-30 )

Largest Industry Peers for Drug Manufacturers - Specialty & Generic

Symbol Name Price(Change) Market Cap
ZTS Zoetis Inc

+0.97 (+0.62%)

USD 66.32B
HLN Haleon plc

-0.13 (-1.26%)

USD 45.41B
TAK Takeda Pharmaceutical Co Ltd A..

+0.01 (+0.07%)

USD 43.84B
RDY Dr. Reddy’s Laboratories Ltd..

-0.02 (-0.14%)

USD 11.39B
ELAN Elanco Animal Health

-0.26 (-2.67%)

USD 4.28B
AMRX Amneal Pharmaceuticals, Inc. C..

-0.09 (-1.16%)

USD 3.25B
BHC Bausch Health Companies Inc

-0.21 (-3.81%)

USD 1.60B
CPHI China Pharma Holdings Inc

+0.23 (+11.98%)

USD 4.61M
YCBD cbdMD Inc

-0.03 (-11.94%)

USD 1.44M
EBS Emergent Biosolutions Inc

-0.11 (-2.02%)

N/A

ETFs Containing PRGO

FLWR:SW 15.27 % 0.00 %

N/A

N/A
LIMI Themes Lithium & Battery .. 10.46 % 0.00 %

-0.13 (-0.60%)

USD 0.44M
XMET:AU BetaShares Energy Transit.. 4.93 % 0.00 %

-0.01 (-0.60%)

N/A
GNRX 0.00 % 0.55 %

N/A

N/A
PILL Direxion Daily Pharmaceut.. 0.00 % 0.98 %

+0.04 (+-0.60%)

N/A
XPH SPDR® S&P Pharmaceutical.. 0.00 % 0.35 %

+0.12 (+-0.60%)

N/A
ISRL:LSE 0.00 % 0.00 %

N/A

N/A
TASE:LSE 0.00 % 0.00 %

N/A

N/A
QDVM:F 0.00 % 0.00 %

N/A

N/A
QDVM:XETRA 0.00 % 0.00 %

N/A

N/A
WSRD:CA Wealthsimple Developed Ma.. 0.00 % 0.00 %

+0.21 (+-0.60%)

CAD 0.81B
FLWG:LSE 0.00 % 0.00 %

N/A

N/A
FLWR:LSE 0.00 % 0.00 %

N/A

N/A
BLUM:XETRA 0.00 % 0.00 %

N/A

N/A
HLIT:CA Global X Lithium Producer.. 0.00 % 0.00 %

-0.09 (-0.60%)

CAD 0.02B
BLUM:F 0.00 % 0.00 %

N/A

N/A
ION Proshares S&P Global Core.. 0.00 % 0.00 %

-0.14 (-0.60%)

USD 2.31M

Market Performance

  Market Performance vs. Industry/Classification (Drug Manufacturers - Specialty & Generic) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.04% 71% C- 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.04% 71% C- 62% D
Trailing 12 Months  
Capital Gain -21.82% 29% F 14% F
Dividend Return 2.52% 50% F 46% F
Total Return -19.31% 29% F 14% F
Trailing 5 Years  
Capital Gain -51.18% 46% F 8% B-
Dividend Return 9.25% 40% F 20% F
Total Return -41.93% 46% F 8% B-
Average Annual (5 Year Horizon)  
Capital Gain -12.98% 6% D- 5% F
Dividend Return -10.47% 6% D- 5% F
Total Return 2.51% 88% B+ 56% F
Risk Return Profile  
Volatility (Standard Deviation) 8.04% 100% F 83% B
Risk Adjusted Return -130.11% 6% D- N/A F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.